Modular Medical Announces Conference Call to Provide Business Update
Rhea-AI Summary
Modular Medical (Nasdaq: MODD), a company specializing in FDA-cleared patch pump technology for insulin delivery, has announced a conference call and webcast scheduled for December 5, 2024, at 10:00 a.m. Eastern Time. The company will provide a business update during this call.
Participants can join via phone using 1-888-506-0062 (US) or +1-973-528-0011 (International) with passcode 494842. A webcast replay will be available on the company's website, and a conference call replay will be accessible until December 19, 2024, using 1-877-481-4010 (US) or 1-919-882-2331 (International) with passcode 51725.
Positive
- None.
Negative
- None.
News Market Reaction – MODD
On the day this news was published, MODD declined 1.75%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.
Conference Call and Webcast Information
Date: December 5, 2024
Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)
Conference Call Number: 1-888-506-0062
International Call Number: +1-973-528-0011
Passcode: 494842
Webcast: CLICK HERE
For those unable to listen to the live Web broadcast, an archived webcast will be available on the Company's investor relations page at www.modular-medical.com. A replay of the conference call will also be available through December 19, 2024, and can be accessed by calling 1-877-481-4010 and using passcode 51725. International callers should dial 1-919-882-2331 and enter the same passcode at the prompt.
About Modular Medical
Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on accesswire.com
FAQ
When is Modular Medical (MODD) hosting its business update conference call?
How can investors access the Modular Medical (MODD) conference call replay?
What is the conference call number and passcode for Modular Medical's (MODD) December 5 update?
